Jushi Holdings (JUSHF) Change in Receivables (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Change in Receivables of $336000.0 for Q2 2026, up 112.03% year-over-year from $158464.9 in Q2 2025, and up 184.85% quarter-over-quarter from -$396000.0 in Q1 2026.
Jushi Holdings (JUSHF) Change in Receivables (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Change in Receivables for 6 consecutive years, with $336000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Receivables rose 112.03% year-over-year to $336000.0; the TTM figure through Jun 2026 stood at $2.0 million (up 242.21% YoY), while the FY2025 annual figure was $1.1 million, up 160.44% from the prior year.
- Change in Receivables climbed to $336000.0 in Q2 2026 per JUSHF's latest filing, from -$396000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.8 million in Q1 2025 and bottomed at -$2.8 million in Q2 2025.
- Historically, Change in Receivables has averaged $175722.2 across 5 years, with a median of $423500.0 in 2022.
- On a YoY basis, Change in Receivables climbed as much as 551.22% in 2025 and fell as far as 184.03% in 2025.
- Jushi Holdings' Change in Receivables stood at $1.5 million in 2022, then tumbled by 43.93% to $855000.0 in 2023, then slumped by 123.51% to -$201000.0 in 2024, then jumped by 538.31% to $881000.0 in 2025, then tumbled by 61.86% to $336000.0 in 2026.
- Business Quant data shows JUSHF's Change in Receivables at $336000.0 in Q2 2026, -$396000.0 in Q1 2026, and $881000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | -396,000.00 |
| Mar 31, 2026 | -396,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -201,000.00 |
| Dec 31, 2024 | -201,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Mar 31, 2024 | -410,000.00 |
| Mar 31, 2024 | -410,000.00 |